Top Vendors in the AI in Pathology Market & Their Offerings
| Company | Headquaters | Offerings |
| Roche Diagnostics | Basel, Switzerland | Through its tissuediagnostics arm, Roche provides AI-powered digital pathology systems and integrates third-party AI algorithms for cancer diagnostics, companion diagnostics, and workflow automation. |
| Philips Healthcare | Amsterdam/Netherlands | Offers wholeslide scanners, Image Management System (IMS), digital pathology openplatform, and supports integration with AI tools to enable remote, cloud-based pathology workflows. |
| Leica Biosystems | Nuuloch, Germany | Provides digitalpathology scanners and imagemanagement/analysis systems, enabling labs to digitize slides, a foundation for AI-based pathology workflows. |
| 3D HISTECH | Budapest, Hungary | Offers wholeslide scanners (PANNORAMIC series), digital microscopy, workflow management software imageanalysis solutions supporting both research and diagnostic digital pathology. |
| Hamamatsu Photonic | Japan | Supplies high-resolution imaging/slidescanner hardware and imaging systems; their scanners are used in digitalpathology workflows, enabling slide digitization as a prerequisite for AI/image analysis. |
| Inspirata | Tampa, Florida | Offers digital pathology workflow and management solutions, facilitating AI-enabled image analysis and pathology lab interoperability (as part of the wider market’s AI ecosystem). |
| Proscia | Philadelphia, USA | Provides the Concentriq® platform a cloud-native digital pathology platform with AI-powered image analysis, slide management, and support for labs, research, and pharma, enabling scalable AI pathology workflows. |
| PathAI | Boston, USA | Develops AI-powered diagnostic algorithms (tumor detection, grading, biomarker analysis), and offers AISight® image management system for labs and biopharma; collaborates with major diagnostics players to integrate AI into pathology workflows. |
| Paige | New York, USA | Provides AI pathology software (e.g., for cancer detection, biopsy triage) tools, including Constellation™ and Page.AI, helping pathologists flag suspicious regions and quantify tumor features. |
| Ibex Medical Analytics | Tel Aviv, Israel | Offers AI-driven diagnostic tools for cancer and histopathology; these tools are used in clinical labs and integrate with scanners/platforms. |
Market Growth
The global AI in pathology market size was estimated at USD 110.41 million in 2025 and is predicted to increase from USD 139.7 million in 2026 to approximately USD 1161.3 million by 2035, expanding at a CAGR of 26.53% from 2026 to 2035.
Recent Developments in the AI in Pathology Market
- In August 2025, PathAI partnered with Moffitt Cancer Center in a multi-year agreement to implement PathAI’s AISight Dx platform across Moffitt’s pathology operations. The cloud-based system streamlines slide management, viewing, collaboration, and AI integration to improve accuracy and efficiency. The partnership also supports joint research, real-world data generation, clinical studies, and co-development of advanced AI diagnostic tools to further strengthen precision medicine initiatives.
- In July 2025, PathAI introduced the Precision Pathology Network (PPN), a collaborative network of digital pathology labs built on the AISight Image Management System. The initiative provides cutting-edge AI tools such as MET-Predict for detecting MET-amplified tumors, Explore for biomarker discovery, and the PLUTO foundation model to support research partnerships and the development of customized AI models.
Collaborate with our experts to explore the AI in Pathology Market at sales@towardshealthcare.com
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking
